Forward Pharma (FWP) Reports Q2 Loss of $0.20/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
Forward Pharma Reports Second Quarter 2015 Financial and Operational Results
September 8, 2015 4:00 PM EDTCOPENHAGEN, Denmark, Sept. 8, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP) ("We" or "Forward" or "Company"), today reported financial results for the second quarter ended June 30, 2015. Net loss for the second quarter ended June 30, 2015 was $17.7 million, or $0.38 per share versus $3.2 million, or $0.10 per share for second quarter ended June 30, 2014. On a non-GAAP basis, after removing the effect of non-cash income and expense items, our second quarter net loss for 2015 would have been $9.3 million, or $0.20 per share versus $1.8 million or $0.10 per share for the second quarter of 2014.  As of June 30, 2015, the Company had $202.5 million in... More
